USANA Price To Sales Ratio from 2010 to 2024
| USNA Stock | USD 38.50 0.34 0.89% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 0.92 | Current Value 1.14 | Quarterly Volatility 0.43117333 |
Check USANA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USANA Health's main balance sheet or income statement drivers, such as Interest Expense of 175.4 K, Total Revenue of 585.9 M or Gross Profit of 475.7 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0 or PTB Ratio of 2.58. USANA financial statements analysis is a perfect complement when working with USANA Health Valuation or Volatility modules.
USANA | Price To Sales Ratio |
Latest USANA Health's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of USANA Health Sciences over the last few years. Price to Sales Ratio is figured by comparing USANA Health Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on USANA Health sales, a figure that is much harder to manipulate than other USANA Health Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. USANA Health's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in USANA Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.85 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
USANA Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 1.42 | |
| Geometric Mean | 1.34 | |
| Coefficient Of Variation | 30.38 | |
| Mean Deviation | 0.37 | |
| Median | 1.72 | |
| Standard Deviation | 0.43 | |
| Sample Variance | 0.19 | |
| Range | 1.2486 | |
| R-Value | 0.09 | |
| Mean Square Error | 0.20 | |
| R-Squared | 0.01 | |
| Significance | 0.76 | |
| Slope | 0.01 | |
| Total Sum of Squares | 2.60 |
USANA Price To Sales Ratio History
About USANA Health Financial Statements
USANA Health stakeholders use historical fundamental indicators, such as USANA Health's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although USANA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in USANA Health's assets and liabilities are reflected in the revenues and expenses on USANA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USANA Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 0.92 | 1.14 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:Check out the analysis of USANA Health Correlation against competitors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.83 | Revenue Per Share 45.085 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0809 |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.